Cargando…
Serum ceruloplasmin as cancer marker in oral pre-cancers and cancers
BACKGROUND AND AIM: Oxidative stress leads to a compensatory increase in levels of serum ceruloplasmin in patients with such imbalances. Greater than normal serum ceruloplasmin levels are noticed in numerous cancers including the leukemias and Hodgkin's lymphoma. The purpose of the present stud...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531576/ https://www.ncbi.nlm.nih.gov/pubmed/34729047 http://dx.doi.org/10.4103/jcar.jcar_10_21 |
_version_ | 1784586889394651136 |
---|---|
author | Patil, Manisha B. Lavanya, T. Kumari, C. Meena Shetty, Shishir Ram Gufran, Khalid Viswanath, Vipin Swarnalatha, C. Babu, J. Suresh Nayyar, Abhishek Singh |
author_facet | Patil, Manisha B. Lavanya, T. Kumari, C. Meena Shetty, Shishir Ram Gufran, Khalid Viswanath, Vipin Swarnalatha, C. Babu, J. Suresh Nayyar, Abhishek Singh |
author_sort | Patil, Manisha B. |
collection | PubMed |
description | BACKGROUND AND AIM: Oxidative stress leads to a compensatory increase in levels of serum ceruloplasmin in patients with such imbalances. Greater than normal serum ceruloplasmin levels are noticed in numerous cancers including the leukemias and Hodgkin's lymphoma. The purpose of the present study was to estimate and evaluate the efficacy of serum ceruloplasmin levels as a potential biomarker in the early detection of oral potentially malignant epithelial lesions (PMELs) including leukoplakia, oral submucous fibrosis (OSMF), and oral squamous cell carcinoma (OSCC) patients. MATERIALS AND METHODS: The present observational study was conducted over a period of 2 years wherein 100 subjects aged between 18 to 60 years were divided into four groups with Group A consisting of 25 healthy controls, Group B and C with 25 patients each, clinically diagnosed with oral leukoplakia and OSMF and Group D with 25 patients clinically diagnosed and histopathologically proven OSCC. The patients were subjected to incisional biopsy after routine hematological investigation while the same sera samples were used for analysis of serum ceruloplasmin levels. STATISTICAL ANALYSIS USED: Comparison of serum ceruloplasmin levels between the groups was performed using one way analysis of variance (one way ANOVA) test while P < 0.05 was considered statistically significant. RESULTS: The mean serum ceruloplasmin levels were found to be 43.19 ± 1.90mg/dl in subjects of group A, 47.68 ± 1.51mg/dl in group B, 47.74 ± 1.45mg/dl in group C and 47.73 ± 0.74mg/dl in group D. Using one-way ANOVA, statistically significant variations were found in the values of mean serum ceruloplasmin levels in subjects of the four groups (F-value = 59.58, P = 0.0001). CONCLUSIONS: The observations of the present study revealed that serum ceruloplasmin levels were found to be raised in all 3 study groups including oral leukoplakia, OSMF and OSCC as compared to the controls while the results were found to be statistically significant. |
format | Online Article Text |
id | pubmed-8531576 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-85315762021-11-01 Serum ceruloplasmin as cancer marker in oral pre-cancers and cancers Patil, Manisha B. Lavanya, T. Kumari, C. Meena Shetty, Shishir Ram Gufran, Khalid Viswanath, Vipin Swarnalatha, C. Babu, J. Suresh Nayyar, Abhishek Singh J Carcinog Original Article BACKGROUND AND AIM: Oxidative stress leads to a compensatory increase in levels of serum ceruloplasmin in patients with such imbalances. Greater than normal serum ceruloplasmin levels are noticed in numerous cancers including the leukemias and Hodgkin's lymphoma. The purpose of the present study was to estimate and evaluate the efficacy of serum ceruloplasmin levels as a potential biomarker in the early detection of oral potentially malignant epithelial lesions (PMELs) including leukoplakia, oral submucous fibrosis (OSMF), and oral squamous cell carcinoma (OSCC) patients. MATERIALS AND METHODS: The present observational study was conducted over a period of 2 years wherein 100 subjects aged between 18 to 60 years were divided into four groups with Group A consisting of 25 healthy controls, Group B and C with 25 patients each, clinically diagnosed with oral leukoplakia and OSMF and Group D with 25 patients clinically diagnosed and histopathologically proven OSCC. The patients were subjected to incisional biopsy after routine hematological investigation while the same sera samples were used for analysis of serum ceruloplasmin levels. STATISTICAL ANALYSIS USED: Comparison of serum ceruloplasmin levels between the groups was performed using one way analysis of variance (one way ANOVA) test while P < 0.05 was considered statistically significant. RESULTS: The mean serum ceruloplasmin levels were found to be 43.19 ± 1.90mg/dl in subjects of group A, 47.68 ± 1.51mg/dl in group B, 47.74 ± 1.45mg/dl in group C and 47.73 ± 0.74mg/dl in group D. Using one-way ANOVA, statistically significant variations were found in the values of mean serum ceruloplasmin levels in subjects of the four groups (F-value = 59.58, P = 0.0001). CONCLUSIONS: The observations of the present study revealed that serum ceruloplasmin levels were found to be raised in all 3 study groups including oral leukoplakia, OSMF and OSCC as compared to the controls while the results were found to be statistically significant. Wolters Kluwer - Medknow 2021-09-30 /pmc/articles/PMC8531576/ /pubmed/34729047 http://dx.doi.org/10.4103/jcar.jcar_10_21 Text en Copyright: © 2021 Journal of Carcinogenesis https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Patil, Manisha B. Lavanya, T. Kumari, C. Meena Shetty, Shishir Ram Gufran, Khalid Viswanath, Vipin Swarnalatha, C. Babu, J. Suresh Nayyar, Abhishek Singh Serum ceruloplasmin as cancer marker in oral pre-cancers and cancers |
title | Serum ceruloplasmin as cancer marker in oral pre-cancers and cancers |
title_full | Serum ceruloplasmin as cancer marker in oral pre-cancers and cancers |
title_fullStr | Serum ceruloplasmin as cancer marker in oral pre-cancers and cancers |
title_full_unstemmed | Serum ceruloplasmin as cancer marker in oral pre-cancers and cancers |
title_short | Serum ceruloplasmin as cancer marker in oral pre-cancers and cancers |
title_sort | serum ceruloplasmin as cancer marker in oral pre-cancers and cancers |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531576/ https://www.ncbi.nlm.nih.gov/pubmed/34729047 http://dx.doi.org/10.4103/jcar.jcar_10_21 |
work_keys_str_mv | AT patilmanishab serumceruloplasminascancermarkerinoralprecancersandcancers AT lavanyat serumceruloplasminascancermarkerinoralprecancersandcancers AT kumaricmeena serumceruloplasminascancermarkerinoralprecancersandcancers AT shettyshishirram serumceruloplasminascancermarkerinoralprecancersandcancers AT gufrankhalid serumceruloplasminascancermarkerinoralprecancersandcancers AT viswanathvipin serumceruloplasminascancermarkerinoralprecancersandcancers AT swarnalathac serumceruloplasminascancermarkerinoralprecancersandcancers AT babujsuresh serumceruloplasminascancermarkerinoralprecancersandcancers AT nayyarabhisheksingh serumceruloplasminascancermarkerinoralprecancersandcancers |